Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02962596 · ClinicalTrials.gov registry record
EURAD MRI Classification of US Indeterminate Adnexa Lesions
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 1,340
- Enrollment target
NCT02962596 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 1,340 participants.
The verdict
NCT02962596 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 1,340 participants
- Enrollment target
Study Summary
This research is targeting patients with sonographically indeterminate adnexal mass that are being referred for clinical MR imaging. Investigators from the UW will be contributing coded MR images and associated health information (US results, laboratory/pathology results) to the EURAD trial. In addition, outcomes data on each patient will be sent at month 24 of the research.
Interventions
- OTHER ADNEXMR SCORING system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,340 participants |
| Start Date | 2014-02 |
| Est. Completion | 2018-08-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02962596
The ClinicalTrials.gov registry entry for NCT02962596 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,340 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ADNEXMR SCORING system is the first listed.
NCT02962596 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02962596 about?
NCT02962596 is a clinical study titled "EURAD MRI Classification of US Indeterminate Adnexa Lesions". This research is targeting patients with sonographically indeterminate adnexal mass that are being referred for clinical MR imaging. Investigators from the UW will be contributing coded MR images and associated health information (US results, laboratory/pathology results) to the EURAD trial. In addi...
What is the current status of trial NCT02962596?
This trial is currently completed. The enrollment target is 1,340 participants. The study started on 2014-02. Estimated completion is 2018-08-15.
What interventions are being tested in trial NCT02962596?
The interventions under investigation include: ADNEXMR SCORING system (OTHER).
Who is sponsoring clinical trial NCT02962596?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.